AptarGroup (ATR)
Designs dispensing, drug-delivery, closure, and material-science solutions.
Something off on this page? Send us feedback.
Designs dispensing and protection systems for pharmaceutical and consumer products through Pharma, Beauty, and Closures. Drug delivery, pumps, closures, and active material-science solutions serve global end markets.
Designs and manufactures drug-delivery systems, dispensing pumps, aerosol valves, closures, and active material-science solutions. These systems shape how medicines and consumer products are delivered, sealed, and protected. Its technology roots include aerosol valves, spray pumps, and molded dispensing closures. Aptar Pharma serves prescription drugs, consumer health care, injectables, and digital-health-related services; Aptar Beauty serves beauty, personal care, and home care; Aptar Closures serves food, beverage, personal care, home care, beauty, and health care.
Operations span 20 countries, and the business builds capabilities through bolt-on acquisitions, particularly in Pharma. Growth and integration depend on executing acquisitions and operating within regulated environments.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 15, 2026 | Raymond James | Reiterate | Rating: —Target: — | Target: $160 |
| Mar 20, 2026 | Wells Fargo | Upgrade | ||
| Feb 9, 2026 | Robert W. Baird | Target | Target: $145 | Target: $156 |
| Jan 9, 2026 | KeyBanc | Target | Target: — | Target: $220 |
| Jan 6, 2026 | Wells Fargo | Downgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $197.3M · Total debt $1.43B · Total assets $5.13B · Shareholders' equity $2.63B
- Revenue
- $1.03B
- Operating income
- $128.1M
- Net income
- $87.6M
HistoryDividendAnnual yield
| Institutions | 97.37% | 61.91M shares | |
|---|---|---|---|
| 562 holders · as of Jun 30, 2026 | |||
| Insiders | 0.78% | 494.9K shares | |
| 20 holders · as of Sep 11, 2026 | |||
| Other | 1.85% | 1.18M shares | |
| remainder | |||
63.58M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 9.65% | 6.14M | as of Jun 30, 2026 |
State Farm Mutual Automobile Insurance CoInstitution | 7.46% | 4.74M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.72% | 3.64M | as of Jun 30, 2026 |
Morgan StanleyInstitution | 5.54% | 3.52M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 4.55% | 2.89M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 2, 2026 | Shiela Vinczeller | officer: Chief Human Resources Officer | −765 | $130.37 |
| Aug 27, 2026 | Gael Touya | officer: Segment Pres., CEO Designate | −3,740 | $133.76 |
| Aug 4, 2026 | Marc Prieur | officer: Segment President | −3,500 | $136.26 |
| Aug 3, 2026 | Stephan B. Tanda | director, officer: President and CEO | −9,838 | $136.16 |
| Aug 3, 2026 | Hedi Tlili | officer: Segment President | −8,854 | $135.00 |
- West Pharmaceutical Services
Injectable-drug containment and delivery systems
- Stevanato Group
Drug containment and delivery for pharma and biotech
- Silgan
Dispensing and specialty closures across consumer end markets
- TriMas
Specialty closures and dispensing systems for consumer packaging
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| AptarGroup | $124.20 | +0.65% | $7.88B | 22.3 | 20.9 | 2.0 | +6.3% |
| West Pharmaceutical Services | $366.72 | +1.37% | $25.46B | 46.3 | 39.7 | 7.7 | +13.9% |
| Stevanato Group | $21.45 | −0.30% | $5.87B | 39.1 | 27.4 | 4.2 | +4.6% |
| Silgan | $37.44 | +0.94% | $3.92B | 14.6 | 9.6 | 0.6 | +6.8% |
| TriMas | $38.51 | +1.72% | $1.36B | 1.6 | 19.6 | 1.8 | −36.5% |
| Median | 26.8 | 23.5 | 3.0 | +5.7% |